AGIO
NASDAQ · Biotechnology
Agios Pharmaceuticals Inc
$32.27
+0.32 (+1.00%)
Open$32.32
Previous Close$31.95
Day High$32.61
Day Low$31.55
52W High$46.00
52W Low$22.24
Volume—
Avg Volume1.35M
Market Cap1.91B
P/E Ratio—
EPS$-7.01
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-66.3% upside
Current
$32.27
$32.27
Target
$10.87
$10.87
$8.41
$10.87 avg
$14.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 59.22M | 37.97M | 198.27M |
| Net Income | -452,431,235 | -261,068,225 | -11,344,752 |
| Profit Margin | -764.0% | -725.8% | -5.7% |
| EBITDA | -511,803,145 | -311,734,941 | -15,767,673 |
| Free Cash Flow | — | — | -7,306,109 |
| Rev Growth | +56.0% | +56.0% | -2.9% |
| Debt/Equity | — | — | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |